136879-36-2 = 78834-75-0 反应条件:1.1 Reagents: Formaldehyde,Nitrosylsulfuric Acid Solvents: Water 标题:Development And Validation Of Gc-Ms Method For The Trace Level Determination Of Structurally Alert Alkyl Halide Impurities In Cilastatin Sodium Drug Substance 作者:Raja,K. Durga; Ramana,V. Saradhi Venkata; Babu,K. Raghu; Babu,B. Kishore; Kumar,Vundavilli Jagadeesh; Et Al 参考文献:International Journal Of Pharmaceutical Sciences And Research 日期:2020 卷标:11(10) 页码:5017-5026
6-氯-1-己醇置于硫酸,Potassium Bromide 盐酸,Sodium Hypochlorite,2,2,6,6-四甲基哌啶氧化物,水,碳酸氢钠,Sodium Hydrogensulfite体系中,用 二氯甲烷,水 作为反应溶剂,化学反应 158.0H,反应生成 7-氯-2-氧代庚酸乙酯 参考文献:Intermediate Of Cilastatin And Preparation Method Thereof 标题:Intermediate Of Cilastatin And Preparation Method Thereof
专利号:US-5268501-A 优先权日:1990-02-08 标 题 :Process for preparing haloketo acid derivatives 发明人:IKEDA TAKAHARU; KAI SEIICHI; MINAI MASAYOSHI 权利人:SUMITOMO CHEMICAL CO 摘要:Process for preparing haloketo acid derivatives [I]: ##STR1## wherein R is H or C 1-6 alkyl, and X is chlorine or bromine, which comprises reacting β-oxo-acid ester [II]: ##STR2## wherein R 1 is H or C 1-6 alkyl, R 2 is C 1-5 alkyl or OR 3 (R 3 is C 1-6 alkyl), and X is the same as above, with nitrosating agent [IV]: n n ONOR.sup.4 [IV] n n wherein R 4 is H, alkyl, halogen or SO 3 H to give 7-halo-2-hydroxyminoheptanoic acid ester [III]: ##STR3## wherein R 1 and X are the same as above, following by reacting the product with aldehyde or ketone; and intermediates therefor, and process for preparing said intermediates. Said haloketo acid derivatives are useful as intermediate for synthesis of cilastatin, which is useful as medicament, especially as dehydropeptidase inhibitor.
专利号:US-5202467-A 优先权日:1990-02-08 标题:Process for preparing haloketo acid derivatives 发明人:IKEDA TAKAHARU; KAI SEIICHI; MINAI MASAYOSHI 权利人:SUMITOMO CHEMICAL CO 摘要:Process for preparing haloketo acid derivatives [I]: ##STR1## wherein R is H or C 1-6 alkyl, and X is chlorine or bromine, which comprises reacting β-oxo-acid ester [II]: ##STR2## wherein R 1 is C 1-6 alkyl, R 2 is C 1-5 alkyl or OR 3 (R 3 is C 1-6 alkyl), and X is the same as above, with nitrosating agent [IV]: n n ONOR.sup.4 [IV] n n wherein R 4 is H, alkyl, halogen or SO 3 H to give 7-halo-2-hydroxyiminoheptanoic acid ester [III]: ##STR3## wherein R 1 and X are the same as above, followed by reacting the product with aldehyde or ketone; and intermediates therefor, and process for preparing said intermediates. Said haloketo acid derivatives are useful as intermediate for synthesis of cilastatin, which is useful as medicament, especially as dehydropeptidase inhibitor.
参考文献:10.1074/jbc.ra119.010201 摘要:Clausse V, Tao D, Debnath S, Fang Y, Tagad HD, Wang Y, Sun H, LeClair CA, Mazur SJ, Lane K, Shi Z, Vasalatiy O, Eells R, Baker LK, Henderson MJ, Webb MR, Shen M, Hall MD, Appella E, Appella DH, Coussens NP. Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. Journal of Biological Chemistry. 2019 Nov;294(46):17654–68. doi: 10.1074/jbc.ra119.010201. 参考文献:10.1177/2472555219873068 摘要:Lee OW, Austin S, Gamma M, Cheff DM, Lee TD, Wilson KM, Johnson J, Travers J, Braisted JC, Guha R, Klumpp-Thomas C, Shen M, Hall MD. Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. SLAS Discov. 2020 Jan;25(1):9–20.